CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | SCHELLER RICHARD H Director | Sale | −100 | $25.19 | $3K | 49,500 |
| 2021-04-30 | Chacko Jacob President and CEO | Sale | −600 | $25.24 | $15K | 60,400 |
| 2021-04-28 | Heyman Richard A. Director | Sale | −100 | $25.08 | $3K | 227,300 |
| 2021-04-28 | SCHELLER RICHARD H Director | Sale | −200 | $25.11 | $5K | 49,600 |
| 2021-04-28 | Chacko Jacob President and CEO | Sale | −700 | $25.06 | $18K | 61,000 |
| 2021-04-01 | SCHELLER RICHARD H Director | Sale | −200 | $25.00 | $5K | 49,800 |
| 2021-04-01 | Heyman Richard A. Director | Sale | −100 | $25.00 | $3K | 227,400 |
| 2021-04-01 | Chacko Jacob President and CEO | Sale | −800 | $25.09 | $20K | 61,700 |
| 2021-03-30 | GORDON CARL L Director | Sale | −27,869 | $23.93 | $667K | 2,212,571 |
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Sale | −27,869 | $23.93 | $667K | 2,212,571 |
| 2021-03-29 | GORDON CARL L Director | Sale | −75,555 | $23.31 | $1.8M | 2,240,440 |
| 2021-03-29 | ORBIMED ADVISORS LLC Director | Sale | −75,555 | $23.31 | $1.8M | 2,240,440 |
| 2021-03-26 | ORBIMED ADVISORS LLC Director | Sale | −27,816 | $23.88 | $664K | 2,315,995 |
| 2021-03-26 | GORDON CARL L Director | Sale | −27,816 | $23.88 | $664K | 2,315,995 |
| 2021-03-25 | ORBIMED ADVISORS LLC Director | Sale | −51,523 | $24.70 | $1.3M | 2,343,811 |
| 2021-03-25 | GORDON CARL L Director | Sale | −51,523 | $24.70 | $1.3M | 2,343,811 |
| 2021-03-24 | ORBIMED ADVISORS LLC Director | Sale | −32,959 | $24.80 | $817K | 2,395,334 |
| 2021-03-24 | GORDON CARL L Director | Sale | −32,959 | $24.80 | $817K | 2,395,334 |
| 2021-03-23 | GORDON CARL L Director | Sale | −3,992 | $24.32 | $97K | 2,428,293 |
| 2021-03-23 | ORBIMED ADVISORS LLC Director | Sale | −3,992 | $24.32 | $97K | 2,428,293 |
Page 14 of 18 · 353 trades